Restarting the global economy for billions of people will depend on successfully overcoming logistical challenges in the 'last mile' of a COVID-19 vaccine's journey to immunization stations, according to a new report.
Nov 25, 2020
0
2
France on Tuesday was set to become the latest country to ease coronavirus restrictions in the run-up to Christmas, as Russia joined in a flurry of encouraging announcements about possible vaccines.
Nov 24, 2020
0
1
Hopes over COVID-19 vaccines have given a boost to virus-weary citizens across the globe in recent days, but the disease remains rampant and world leaders are urging people to be patient.
Nov 24, 2020
0
2
I live in a democracy. But as Thanksgiving approaches, I find myself longing for the type of freedom I am seeing in China.
Nov 23, 2020
1
3
The availability of adequate health care facilities is one of the most important factors that public-health policymakers grapple with when preparing for infectious disease outbreaks such as COVID-19.
Nov 23, 2020
0
2
British drugs group AstraZeneca and the University of Oxford said on Monday they will seek regulatory approval for their coronavirus vaccine after "effective" trials, in the latest potential boost to curbing the global outbreak.
Nov 23, 2020
0
1
G20 leaders said Sunday they will "spare no effort" to ensure the fair distribution of coronavirus vaccines worldwide, and support poor countries whose economies have been ravaged by the crisis.
Nov 22, 2020
0
2
Canada's largest city is going back into lockdown because of a surge in COVID-19 cases.
Nov 20, 2020
0
2
US giant Pfizer and its German partner BioNTech prepared Friday to file an emergency request to roll out their vaunted vaccine while New York shut its schools and California braced for nighttime curfews heading into the US ...
Nov 20, 2020
0
1
Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.
Nov 12, 2020
0
4
